Results: 1-25 | 26-50 | 51-68
Results: 1-25/68

Authors: BRAY PF CANNON CP GOLDSCHMIDTCLERMONT P MOYE LA RICHARDSON C PFEFFER MA SACKS FM BRAUNWALD E
Citation: Pf. Bray et al., THE PIA2 FORM OF PLATELET GPIIIA IS A RISK FACTOR FOR RECURRENT CORONARY EVENTS AND INFLUENCES RESPONSE TO PRAVASTATIN, Journal of investigative medicine, 46(3), 1998, pp. 200-200

Authors: SACKS FM MCMANUS K
Citation: Fm. Sacks et K. Mcmanus, WEIGHT-REDUCTION - A COMPARISON OF A HIGH UNSATURATED FAT DIET WITH NUTS VS A LOW-FAT DIET, The FASEB journal, 12(5), 1998, pp. 3775-3775

Authors: SACKS FM
Citation: Fm. Sacks, HOT PAPERS - CORONARY-DISEASE - THE EFFECT OF PRAVASTATIN ON CORONARYEVENTS AFTER MYOCARDIAL-INFARCTION IN PATIENTS WITH AVERAGE CHOLESTEROL LEVELS BY SACKS,F.M., PFEFFER,M.A., MOYE,L.A., ROULEAU,J.L., RUTHERFORD,J.D., COLE,T.G., BROWN,L., WARNICA,J.W., ARNOLD,J.M.O., WUN,C.C.,DAVIS,B.R., BRAUNWALD,E. - COMMENTS, The Scientist, 12(12), 1998, pp. 11-11

Authors: LEWIS SJ SACKS FM MITCHELL JS EAST C GLASSER S KELL S LETTERER R LIMACHER M MOYE LA ROULEAU JL PFEFFER MA BRAUNWALD E
Citation: Sj. Lewis et al., EFFECT OF PRAVASTATIN ON CARDIOVASCULAR EVENTS IN WOMEN AFTER MYOCARDIAL-INFARCTION - THE CHOLESTEROL AND RECURRENT EVENTS (CARE) TRIAL, Journal of the American College of Cardiology, 32(1), 1998, pp. 140-146

Authors: ARNOLD JMO DAVIS BR NASH DT INSUL W LEWIS S KOHN RM GLASSER SP BELEW KM KIMMEL B SACKS FM
Citation: Jmo. Arnold et al., LIPID-LEVELS, ADHERENCE TO MEDICATION, BASE-LINE CHARACTERISTICS IN THE CHOLESTEROL AND RECURRENT EVENTS (CARE) STUDY, Journal of the American College of Cardiology, 31(2), 1998, pp. 89-89

Authors: SACKS FM WILLETT WC SMITH A BROWN LE ROSNER B MOORE TJ
Citation: Fm. Sacks et al., EFFECT ON BLOOD-PRESSURE OF POTASSIUM, CALCIUM, AND MAGNESIUM IN WOMEN WITH LOW HABITUAL INTAKE, Hypertension, 31(1), 1998, pp. 131-138

Authors: PLEHN JF ROULEAU JL PFEFFER MA DAVIS BR BERNSTEIN V CUDDY TE MOYE LA PILLER LB RUTHERFORD JD SIMPSON LM BRAUNWALD E SACKS FM
Citation: Jf. Plehn et al., REDUCTION OF STROKE INCIDENCE FOLLOWING MYOCARDIAL-INFARCTION WITH PRAVASTATIN - THE CARE STUDY, Stroke, 29(1), 1998, pp. 70-70

Authors: SU WF CAMPOS H JUDGE H WALSH BW SACKS FM
Citation: Wf. Su et al., METABOLISM OF APO(A) AND APOB100 OF LIPOPROTEIN(A) IN WOMEN - EFFECT OF POSTMENOPAUSAL ESTROGEN REPLACEMENT, The Journal of clinical endocrinology and metabolism, 83(9), 1998, pp. 3267-3276

Authors: RIDKER PM RIFAI N PFEFFER MA SACKS FM MOYE LA GOLDMAN S FLAKER GC BRAUNWALD E
Citation: Pm. Ridker et al., INFLAMMATION, PRAVASTATIN, AND THE RISK OF CORONARY EVENTS AFTER MYOCARDIAL-INFARCTION IN PATIENTS WITH AVERAGE CHOLESTEROL LEVELS, Circulation, 98(9), 1998, pp. 839-844

Authors: KHOO C CAMPOS H SACKS FM
Citation: C. Khoo et al., THE NORMAL DIURNAL PATTERN OF POSTPRANDIAL INTESTINAL APO-B-CONTAINING LIPOPROTEINS - POSSIBLE ROLE OF APOCIII CONTENT, Circulation, 98(17), 1998, pp. 148-148

Authors: TOMIYASU K WALSH BW JUDGE H SACKS FM
Citation: K. Tomiyasu et al., DIFFERENTIAL METABOLISM OF VLDL AND IDL PARTICLES THAT DO OR DO NOT CONTAIN APOLIPOPROTEIN-E - KINETIC-STUDIES IN POSTMENOPAUSAL WOMEN, Circulation, 98(17), 1998, pp. 170-170

Authors: KHOO C CAMPOS H DALY G SACKS FM
Citation: C. Khoo et al., DIURNAL CHANGES IN POSTPRANDIAL VLDL PARTICLES ARE LINKED TO APOCIII NOT APOE CONTENT, Circulation, 98(17), 1998, pp. 1238-1238

Authors: BROWN L SESTIER F NASH DT CUDDY TE WILT TJ HOWARD J MOYE LA SIMPSON L SACKS FM
Citation: L. Brown et al., CORONARY RISK-FACTORS PREDICT RECURRENT CORONARY EVENTS AFTER MYOCARDIAL-INFARCTION, Circulation, 98(17), 1998, pp. 1691-1691

Authors: SACKS FM ALAUPOVIC P MOYE LA COLE TG STAMPFER MJ BRAUNWALD E
Citation: Fm. Sacks et al., NEW LIPOPROTEIN PREDICTORS OF RECURRENT CORONARY EVENTS - VLDL PARTICLE CONCENTRATION, VLDL LIPID-CONTENT, AND APOLIPOPROTEIN-CIII AND APOLIPOPROTEIN-E, Circulation, 98(17), 1998, pp. 4145-4145

Authors: ARNOLD JMO DAVIS BR NASH DT INSULL W LEWIS S KOHN RM GLASSER SP BELEW KM KIMMEL B ZIMBALDI NC SACKS FM
Citation: Jmo. Arnold et al., INFLUENCE OF PATIENT ADHERENCE TO TREATMENT BY PILL COUNT AND CLINICAL OUTCOMES IN THE CHOLESTEROL AND RECURRENT EVENTS (CARE) STUDY, Circulation, 98(17), 1998, pp. 4258-4258

Authors: SACKS FM MOYE LA DAVIS BR COLE TG ROULEAU JL NASH DT PFEFFER MA BRAUNWALD E
Citation: Fm. Sacks et al., RELATIONSHIP BETWEEN PLASMA LDL CONCENTRATIONS DURING TREATMENT WITH PRAVASTATIN AND RECURRENT CORONARY EVENTS IN THE CHOLESTEROL AND RECURRENT EVENTS TRIAL, Circulation, 97(15), 1998, pp. 1446-1452

Authors: LEWIS SJ MOYE LA SACKS FM JOHNSTONE DE TIMMIS G MITCHELL J LIMACHER M KELL S GLASSER SP GRANT J DAVIS BR PFEFFER MA BRAUNWALD E
Citation: Sj. Lewis et al., EFFECT OF PRAVASTATIN ON CARDIOVASCULAR EVENTS IN OLDER PATIENTS WITHMYOCARDIAL-INFARCTION AND CHOLESTEROL LEVELS IN THE AVERAGE RANGE - RESULTS OF THE CHOLESTEROL AND RECURRENT EVENTS (CARE) TRIAL, Annals of internal medicine, 129(9), 1998, pp. 681

Authors: GARLAND M SACKS FM HUNTER DJ
Citation: M. Garland et al., DIFFERENCE BETWEEN ANIMAL AND VEGETABLE TRANS-FATTY-ACIDS - REPLY, The American journal of clinical nutrition, 68(4), 1998, pp. 919-919

Authors: GARLAND M SACKS FM COLDITZ GA RIMM EB SAMPSON LA WILLETT WC HUNTER DJ
Citation: M. Garland et al., THE RELATION BETWEEN DIETARY-INTAKE AND ADIPOSE-TISSUE COMPOSITION OFSELECTED FATTY-ACIDS IN US WOMEN, The American journal of clinical nutrition, 67(1), 1998, pp. 25-30

Authors: SACKS FM
Citation: Fm. Sacks, SECTION III - SHOULD SEPARATE END-POINT TRIALS BE REQUIRED FOR ALL LIPID-LOWERING DRUGS ACTING BY THE SAME MECHANISM - PRESENTATION III, The American journal of cardiology, 81(8A), 1998, pp. 90-92

Authors: BLACK DM ORLOFF DG BILHEIMER DW SHEPHERD J OLSSON AG SACKS FM PAOLETTI R CATAPANO A
Citation: Dm. Black et al., SECTION III - SHOULD SEPARATE END-POINT TRIALS BE REQUIRED FOR ALL LIPID-LOWERING DRUGS ACTING BY THE SAME MECHANISM - SECTION III DISCUSSION, The American journal of cardiology, 81(8A), 1998, pp. 92-94

Authors: KHOO C CAMPOS H JUDGE H SACKS FM
Citation: C. Khoo et al., APOLIPOPROTEIN (APO)-E AND (APO)-CIII ENRICHED PARTICLES IN YOUNG-WOMEN - METABOLIC IMPLICATIONS, The FASEB journal, 11(3), 1997, pp. 971-971

Authors: LEWIS SJ MITCHELL J EAST C GLASSER SP GRANT J JOHNSTONE DE KELL S LETTERER R LIMACHER M TIMMIS GC MOYE L ROULEAU J PFEFFER MA SACKS FM BRAUNWALD E
Citation: Sj. Lewis et al., OLDER PATIENTS IN CARE BENEFIT FROM PRAVASTATIN POST MYOCARDIAL-INFARCTION, Journal of the American College of Cardiology, 29(2), 1997, pp. 7871-7871

Authors: APPEL LJ MOORE TJ OBARZANEK E VOLLMER WM SVETKEY LP SACKS FM BRAY GA VOGT TM CUTLER JA WINDHAUSER MM LIN PH KARANJA N
Citation: Lj. Appel et al., A CLINICAL-TRIAL OF THE EFFECTS OF DIETARY PATTERNS ON BLOOD-PRESSURE, The New England journal of medicine, 336(16), 1997, pp. 1117-1124

Authors: SACKS FM PFEFFER MA BRAUNWALD E
Citation: Fm. Sacks et al., THE EFFECT OF PRAVASTATIN ON CORONARY EVENTS AFTER MYOCARDIAL-INFARCTION - REPLY, The New England journal of medicine, 336(13), 1997, pp. 962-962
Risultati: 1-25 | 26-50 | 51-68